Global Leigh Syndrome Treatment Market
市场规模(十亿美元)
CAGR : %
Forecast Period |
2023 –2030 |
Market Size (Base Year) |
USD 200.00 Million |
Market Size (Forecast Year) |
USD 331.00 Million |
CAGR |
|
Major Markets Players |
>全球 Leigh 综合征治疗市场,按类型(线粒体 DNA 相关 Leigh 综合征、核基因编码 Leigh 综合征)、治疗(磁共振成像(MRI)、计算机断层扫描 (CT)、实验室测试等)、给药途径(口服、肠胃外、其他)、治疗(药物、手术等)、最终用户(医院、专科诊所、其他)、分销渠道(医院药房、零售药房、网上药房等)划分 – 行业趋势和预测到 2030 年。
Leigh 综合征治疗市场分析和规模
预计全球 Leigh 综合征治疗市场将在预测期内出现显著增长。几种 Leigh 病类型症状严重,导致诊断和治疗较晚。这种疾病在儿童时期是致命的,尽管很少有人在青少年时期甚至成年期发病。这种进行性疾病始于 3 个月至 2 岁年龄段的婴儿。Leigh 病最常见的治疗方法是服用硫胺素或维生素 B1。
Data Bridge Market Research 分析了 2023-2030 年预测期内全球 Leigh 综合征治疗市场的增长率。在上述预测期内,全球血吸虫病市场的预期复合年增长率趋于 6.50% 左右。2022 年市场价值为 2 亿美元,到 2030 年将增长至 3.31 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外,Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。
Leigh 综合征治疗市场范围和细分
报告指标 |
细节 |
预测期 |
2023 至 2030 年 |
基准年 |
2022 |
历史岁月 |
2021(可定制为 2015 - 2020) |
定量单位 |
收入(百万美元)、销量(单位)、定价(美元) |
涵盖的领域 |
类型(线粒体 DNA 相关 Leigh 综合征、核基因编码 Leigh 综合征)、治疗(磁共振成像 (MRI)、计算机断层扫描 (CT)、实验室测试等)、给药途径(口服、肠胃外、其他)、治疗(药物、手术等)、最终用户(医院、专科诊所、其他)、分销渠道(医院药房、零售药房、网上药房等) |
覆盖国家 |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
Market Players Covered |
GSK Plc. (U.K.), Bayer AG (Germany), Zimmer Biomet (U.S.), Stryker Corporation (U.S.), Wright Medical Group N.V. (U.S.), Integra LifeSciences (U.S.), Huazhong Pharmaceutical Co., Ltd (China), Zhejiang Tianxin (China) |
Market Opportunities |
|
Market Definition
Leigh syndrome is a rare genetic neurodegenerative disease that rarely occurs in teenagers or adults. Symptoms typically progress quickly. The initial symptoms include loss of appetite, poor sucking ability, loss of head and motor skills, vomiting and seizures. Besides this, other symptoms may include weakness and lack of muscle tone, spasticity, movement disorders, cerebellar ataxia, and peripheral neuropathy, as the condition progresses.
Global Leigh Syndrome Treatment Market Dynamics
Drivers
- Increase Prevalence of Leigh syndrome
According to United Mitochondrial Disease Foundation records, the estimated occurrence of Leigh disease is one in 77,000 births or one per 40,000 births for Leigh and Leigh-like disease. Thus, this factor boost the market growth.
- Increase in Diagnostic Tests
Different diagnostic tests used for treating global leigh syndrome treatment market are increasing the market growth. Tests such as Magnetic Resonance Imaging (MRI) or computed tomography (CT) scans of the brain may be performed as it may reveal abnormal areas in certain parts of the brain. Laboratory tests may also be performed to reveal high levels of acidic waste products in the blood along with the elevated levels of pyruvate and alanine in these patients.
Opportunities
- Increase in the number of research and development activities
The market growth is fuelled by an increase in the number of R&D activities. This will provide beneficial opportunities for the leigh syndrome treatment market growth. To encourage researchers and pharmaceutical companies to develop advanced medicines, the government is funding R&D initiatives.
- Emergence of New Varied Treatments
The new growing research organizations in the market are equipped with and utilize the knowledge of professionals in many clinical disciplines, leading to important advances in understanding leigh syndrome and treatment. The most common treatment for Leigh syndrome is the administration of thiamine (Vitamin B1) or thiamine derivatives. Genetic counseling is always recommended for families of affected individuals having this disorder. Thus, this factor creates much opportunities for the market growth.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified personnel unable to perform these treatments could limit the growth of the global leigh syndrome treatment market during the forecast period.
- High Cost
The huge expenditure that is required for the surgeries and treatment processes hamper the market growth. Several market players make huge investments in manufacturing new and advanced treatment procedures to faster the recovery process and in return the cost is increased.
This global leigh syndrome treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global leigh syndrome treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Leigh Syndrome Treatment Market Scope
The global leigh syndrome treatment market is segmented on the basis of type, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Mitochondrial DNA-Associated Leigh Syndrome
- Nuclear Gene-Encoded Leigh Syndrome
Treatment
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Laboratory Test
- Others
Route of Administration
- Oral
- Parenteral
- Others
End-Users
- Hospitals
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacies
- Others
Leigh Syndrome Treatment Market Regional Analysis/Insights
The global leigh syndrome treatment market is analyzed and market size insights and trends are provided by type, treatment, route of administration, distribution channel and end-user as referenced above.
全球 Leigh 综合征治疗市场报告涉及的主要国家 包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于线粒体疾病的增加,预测期内北美将占据市场主导地位。
由于仿制药数量的增加,亚太地区未来几年预计将实现增长。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外,在提供国家数据预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和全球 Leigh 综合征治疗市场份额分析
全球 Leigh 综合征治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球 Leigh 综合征治疗市场的关注有关
全球 Leigh 综合征治疗市场的主要参与者包括:
- 葛兰素史克公司(英国)
- 拜耳公司(德国)
- Zimmer Biomet(美国)
- 史赛克公司 (美国)
- Wright Medical Group NV(美国)
- Integra LifeSciences(美国)
- 华中制药股份有限公司 (中国)
- 浙江天信(中国)
研究方法:全球 Leigh 综合征治疗市场
数据收集和基准年分析是使用具有大样本量的数据收集模块进行的。市场数据使用市场统计和连贯模型进行分析和估计。市场份额分析和关键趋势分析也是市场报告中的主要成功因素。如需了解更多信息,请请求分析师致电或下拉询问。
DBMR 研究团队使用的关键研究方法是数据三角测量,涉及数据挖掘、数据变量对市场影响的分析以及主要(行业专家)验证。除此之外,数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息,请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们很自豪能够为现有和新客户提供符合其目标的数据和分析。报告可以定制,包括目标品牌的价格趋势分析、了解其他国家的市场(索取国家列表)、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表(Factbook)中的数据,或者可以帮助您根据报告中的数据集创建演示文稿。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.